SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-016873
Filing Date
2022-11-08
Accepted
2022-11-08 16:15:54
Documents
70
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lqda-20220930x10q.htm   iXBRL 10-Q 1805881
2 EX-31.1 lqda-20220930xex31d1.htm EX-31.1 15301
3 EX-31.2 lqda-20220930xex31d2.htm EX-31.2 15302
4 EX-32.1 lqda-20220930xex32d1.htm EX-32.1 7567
5 EX-32.2 lqda-20220930xex32d2.htm EX-32.2 7546
6 GRAPHIC lqda-20220930x10q001.jpg GRAPHIC 631
  Complete submission text file 0001558370-22-016873.txt   7480264

Data Files

Seq Description Document Type Size
7 EX-101.SCH lqda-20220930.xsd EX-101.SCH 51898
8 EX-101.CAL lqda-20220930_cal.xml EX-101.CAL 46473
9 EX-101.DEF lqda-20220930_def.xml EX-101.DEF 208547
10 EX-101.LAB lqda-20220930_lab.xml EX-101.LAB 456805
11 EX-101.PRE lqda-20220930_pre.xml EX-101.PRE 363401
64 EXTRACTED XBRL INSTANCE DOCUMENT lqda-20220930x10q_htm.xml XML 1327789
Mailing Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560
Business Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560 919.328.4400
Liquidia Corp (Filer) CIK: 0001819576 (see all company filings)

IRS No.: 851710962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39724 | Film No.: 221369095
SIC: 2834 Pharmaceutical Preparations